SG Americas Securities’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-444
| Closed | -$15K | – | 2903 |
|
2024
Q1 | $15K | Sell |
444
-1,559
| -78% | -$52.7K | ﹤0.01% | 2513 |
|
2023
Q4 | $54K | Buy |
2,003
+115
| +6% | +$3.1K | ﹤0.01% | 2637 |
|
2023
Q3 | $114K | Buy |
1,888
+501
| +36% | +$30.3K | ﹤0.01% | 2451 |
|
2023
Q2 | $141K | Sell |
1,387
-698
| -33% | -$71K | ﹤0.01% | 1692 |
|
2023
Q1 | $369K | Buy |
2,085
+750
| +56% | +$133K | ﹤0.01% | 1781 |
|
2022
Q4 | $516K | Buy |
1,335
+47
| +4% | +$18.2K | 0.01% | 1336 |
|
2022
Q3 | $434K | Sell |
1,288
-516
| -29% | -$174K | 0.01% | 1478 |
|
2022
Q2 | $593K | Sell |
1,804
-289
| -14% | -$95K | 0.01% | 1649 |
|
2022
Q1 | $915K | Sell |
2,093
-443
| -17% | -$194K | 0.01% | 1317 |
|
2021
Q4 | $1.11M | Sell |
2,536
-40
| -2% | -$17.5K | 0.01% | 1443 |
|
2021
Q3 | $1.43M | Buy |
2,576
+1,780
| +224% | +$990K | 0.01% | 1439 |
|
2021
Q2 | $409K | Sell |
796
-716
| -47% | -$368K | ﹤0.01% | 1840 |
|
2021
Q1 | $1.18M | Sell |
1,512
-2,680
| -64% | -$2.1M | 0.01% | 1274 |
|
2020
Q4 | $2.28M | Buy |
4,192
+495
| +13% | +$270K | 0.01% | 884 |
|
2020
Q3 | $1.69M | Buy |
3,697
+463
| +14% | +$212K | 0.01% | 684 |
|
2020
Q2 | $1.99M | Buy |
3,234
+2,427
| +301% | +$1.49M | 0.02% | 672 |
|
2020
Q1 | $384K | Buy |
807
+296
| +58% | +$141K | ﹤0.01% | 1690 |
|
2019
Q4 | $297K | Buy |
511
+127
| +33% | +$73.8K | ﹤0.01% | 1897 |
|
2019
Q3 | $253K | Sell |
384
-415
| -52% | -$273K | ﹤0.01% | 1926 |
|
2019
Q2 | $618K | Buy |
799
+255
| +47% | +$197K | ﹤0.01% | 1547 |
|
2019
Q1 | $385K | Sell |
544
-2,421
| -82% | -$1.71M | ﹤0.01% | 1812 |
|
2018
Q4 | $1.39M | Buy |
+2,965
| New | +$1.39M | 0.01% | 957 |
|
2017
Q4 | – | Sell |
-704
| Closed | -$347K | – | 3036 |
|
2017
Q3 | $347K | Buy |
+704
| New | +$347K | ﹤0.01% | 1838 |
|